Showing results (2031-2040 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|May 26, 2004
Review of health economics modelling in rheumatoid arthritisPaul EmeryPharmacoeconomics|September 15, 2004
The costs and benefits of community thrombolysis for acute myocardial infarction : a decision-analytic modelLuke Vale, Harvey Steffens, Cam DonaldsonPharmacoeconomics|September 4, 2004
Socioeconomic issues affecting the treatment of obesity in the new millenniumL F Martin, A Robinson, B J MoorePharmacoeconomics|June 26, 2004
Pharmacogenomics and the evolution of healthcare : is it time for cost-effectiveness analysis at the individual level?Mohan V Bala, Gary A ZarkinPharmacoeconomics|June 26, 2004
An economic evaluation of fluvastatin used for the prevention of cardiac events following successful first percutaneous coronary intervention in the UKPaul A Scuffham, Stephen ChaplinPharmacoeconomics|June 26, 2004
Psychometric and utility-based measures of health status of asthmatic patients with different disease control levelAgota Szende, Klas Svensson, Elisabeth Ståhl, et al.Pharmacoeconomics|June 24, 2004
The burden of migraine in Spain: beyond direct costsXavier Badia, Sol Magaz, Laura Gutiérrez, et al.Pharmacoeconomics|July 13, 2004
Warfarin in the secondary prevention of thromboembolism in atrial fibrillation: impact of bioavailability on costs and outcomesNicole Mittmann, Paul I Oh, Scott E Walker, et al.Pharmacoeconomics|March 13, 2002
Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) StudyMark Sculpher, David Millson, David Meddis, et al.Pharmacoeconomics|March 13, 2002
Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluationJonathan Karnon, Jackie Brown, Pageof 336